Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2003
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2481042A1 Mycoplasma polypeptides
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/22/2003EP1355156A2 A human endothelin receptor
10/22/2003EP1354959A1 Process for producing recombinant protein and fused protein
10/22/2003EP1354947A1 Novel polypeptide
10/22/2003EP1354896A1 Novel monoclonal antibody
10/22/2003EP1354894A2 Fusion peptide of human type-1 collagen derived peptide and tat peptide, preparation thereof, and skin anti-aging cosmetic composition comprising the same
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354890A1 Novel polypeptide and dna thereof
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354204A2 Hcv antigen/antibody combination assay
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354053A2 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
10/22/2003EP1354052A2 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354034A2 Transgenic transchromosomal rodents for making human antibodies
10/22/2003EP1353956A1 Method for surface display of proteins on genetic carriers
10/22/2003EP1353955A2 High affinity antibodies
10/22/2003EP1353954A2 Anticoagulants and their uses
10/22/2003EP1353953A2 Mu-1, member of the cytokine receptor family
10/22/2003EP1353950A2 Method and apparatus for the production of antigens and uses thereof
10/22/2003EP1353949A2 Compositions and methods relating to ovary specific genes and proteins
10/22/2003EP1353948A2 Soluble cyclic analogues of the beta amyloide peptide
10/22/2003EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
10/22/2003EP1353945A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/22/2003EP1353937A2 Specific human antibodies for selective cancer therapy
10/22/2003EP1353688A2 Method and compositions for immunization with the pseudomonas v antigen
10/22/2003EP1003872B1 Increasing production of proteins in gram-positive microorganisms
10/22/2003EP0922059B1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
10/22/2003EP0815221B1 A novel growth factor and a genetic sequence encoding same
10/22/2003EP0659217B1 CLONING AND EXPRESSION OF beta APP-C100 RECEPTOR
10/22/2003CN1451048A Expression of biologically active polypeptides in duckweed
10/22/2003CN1451043A Dual specificity antibodies and methods of making and using
10/22/2003CN1451042A Method of monitoring HIV drug resistance
10/22/2003CN1451015A Insect poison allergens with reduced LgE reactivity and method for producing the same
10/22/2003CN1450909A Monoclonal antibodies and antibody cocktail for detection of prion protein as an indiction of transmissible spongiform encephalopathies
10/22/2003CN1450169A Separation purification method for preparing sex-gene recombination spider dragline silk protein
10/22/2003CN1450168A Process for raising glutathion yield by fermentation of tornla yeast
10/22/2003CN1125183C Preparation process of Lidamycin as one antineoplastic antibiotics
10/22/2003CN1125175C Alkaline protease process for production thereof using method thereof and microorganism producing same
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125083C Monoclonal antibody active against CD44V6
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125079C Cyclopeptolides
10/21/2003US6635752 Diagnosis of Aids
10/21/2003US6635745 Rapamycin assay
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635616 Laminin 15
10/21/2003US6635483 Antisense polynucleotide targeted to a nucleic acid encoding the gene, thereby suppressing its expression; cDNA encapsulated in liposome; use as antitumor, anticarcinogenic or antiapoptotic; Alzheimer's disease
10/21/2003US6635482 Produced by hybridoma; cytokines; useful in diagnosis, prevention and treatment of immune system-related disorders
10/21/2003US6635479 Hypothalamus-specific polypeptides
10/21/2003US6635478 Transfecting mammalian cell with a construct for stable expression of a gene product and a second construct comprising a antibiotic resistance gene; use in drug discovery
10/21/2003US6635474 Recombinant vector plasmids for producing proteins which maintain their normal activity; useful for scale-up production, isolating and purifying with ease and safety; Human granulocyte colony stimulating factor
10/21/2003US6635468 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/21/2003US6635454 DNA molecules coding for debranching enzymes derived from plants
10/21/2003US6635449 Exonuclease-mediated nucleic acid reassembly in directed evolution
10/21/2003US6635447 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635429 Incubating a cell containing sequence linked to a DNA response element with an agent to determine its capability of transactivating the sequence; retinoic acid, thyroid, retinoid X
10/21/2003US6635256 Administering multiple domain glycoprotein hormones containing alpha subunit covalently linked to beta subunit to form single chain hormone and additional beta subunit noncovalently linked to tethered alpha subunit of single chain hormone
10/21/2003US6635252 Antibodies to superoxide dismutase-4
10/21/2003US6635248 Isolated polypeptide consisting of single chain of amino acids comprising one or more penetrating fragments from one or more penetrating antibodies, which penetrates into cell
10/21/2003CA2182289C Immuno-stimulatory monoclonal antibodies
10/21/2003CA2157659C Use of porcine gal .alpha. (1,3) galactosyl transferase in xenograft therapies
10/21/2003CA2156825C Inhibition of intimal hyperplasia using antibodies to pdgf receptors
10/21/2003CA2132452C Casein kinase i-like protein kinase
10/21/2003CA2115049C Dna sequences encoding gelonin polypeptide
10/21/2003CA2076432C Humanized antibody derivatives that recognize difucosyl lewis blood group antigens y-6 and b-7-2
10/21/2003CA2066940C Canine coronavirus subunit vaccine
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
10/21/2003CA2017166C Metalloproteinase inhibitor
10/21/2003CA1341444C Modified tissue plasminogen activator
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085375A2 Hcv antiviral and cytotoxicity drug screening assay
10/16/2003WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085119A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcϜ RECEPTOR IIIa
10/16/2003WO2003085118A1 Process for producing antibody composition
10/16/2003WO2003085114A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
10/16/2003WO2003085107A1 Cells with modified genome
10/16/2003WO2003085102A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport
10/16/2003WO2003085096A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085095A2 Novel expressed genes
10/16/2003WO2003085093A2 Antibodies that specifically bind to gmad
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003084998A1 Monoclonal antibody neutralizing megsin
10/16/2003WO2003084991A1 Atopic dermatitis-inducing proteins
10/16/2003WO2003084570A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM FcϜRIIIa POLYMORPHISM
10/16/2003WO2003084569A1 Drug containing antibody composition
10/16/2003WO2003084472A2 Recombinant p. falciparum merozoite protein-142 vaccine
10/16/2003WO2003073238A3 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003059935A3 Methods for purifying protein
1 ... 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 ... 1125